William Blair Investment Management’s GSK GSK Stock Holding History

William Blair Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-74,378	Closed	-$3.88M	–	389
2019 Q1	$3.88M	Buy	74,378 +17,912	+32%	+$895K	0.02%	350
2018 Q4	$2.7M	Buy	56,466 +4,094	+8%	+$202K	0.01%	357
2018 Q3	$2.63M	Buy	+52,372	New	+$2.66M	0.01%	375
2017 Q3	–	Sell	-80,368	Closed	-$4.33M	–	443
2017 Q2	$4.33M	Sell	80,368 -1,555	-2%	-$82.9K	0.02%	361
2017 Q1	$4.32M	Buy	81,923 +4,539	+6%	+$230K	0.02%	355
2016 Q4	$3.73M	Buy	77,384 +182	+0.2%	+$8.99K	0.01%	361
2016 Q3	$4.16M	Buy	77,202 +48,157	+166%	+$2.64M	0.02%	362
2016 Q2	$1.57M	Buy	+29,045	New	+$1.53M	0.01%	392

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

William Blair Investment Management's GSK Position: Q2 2019 in Review

William Blair Investment Management sold out of GSK (GSK) in Q2 2019, closing a stake of 74,378 shares — an estimated $3.88M sold.

William Blair Investment Management first reported a position in GSK in Q2 2016 and held it in 8 quarters. The position peaked at $4.33M in Q2 2017. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

William Blair Investment Management reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
William Blair Investment Management sold 74,378 GSK shares in Q2 2019, an estimated $3.88M.
William Blair Investment Management first reported a position in GSK in Q2 2016 and held it in 8 quarters.
William Blair Investment Management's GSK position peaked at $4.33M in Q2 2017.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on William Blair Investment Management's 13F filing for Q2 2019, filed 9 Aug 2019.